Saikosaponin A – 25 mg

Brand:
Cayman
CAS:
20736-09-8
Storage:
-20
UN-No:
Non-Hazardous - /

Saikosaponin A is a triterpenoid saponin with diverse biological activities, including anti-inflammatory, antiallergic, anticonvulsive, antiproliferative, and antiviral properties.{34440,42259,42260,42262} Saikosaponin A reduces expression of TNF-α, IL-6, and IL-1β in primary mouse macrophages stimulated by LPS.{42257} It also increases the survival rate in mice with LPS-induced lethal endotoxemia in a dose-dependent manner.{42257} Saikosaponin A (20 mg/kg, i.v., per day) reduces weight loss, brain edema, blood-brain barrier disruption, and IL-6 and TNF-α protein levels in the ipsilateral cortex compared to control animals in a rat model of traumatic brain injury.{42258} It also reduces the number of nasal rubs and levels of serum TNF-α in an ovalbumin-sensitized allergic rhinitis mouse model in vivo when administered at a dose of 8 mg/kg.{42259} It reduces the duration and frequency of epileptiform activity in rat hippocampal CA1 neurons in a dose-dependent manner in a 4-aminopyridine (4-AP; Item No. 18511) seizure model.{42260} Saikosaponin A (20 µM) decreases viability in six human colon carcinoma (HCC), H358 lung and MCF-7 breast cancer, as well as Jurkat and K582 leukemia cell lines.{42261} It also prolongs tumor growth inhibition in LoVo and SW480 HCC mouse xenograft models in vivo when used at a dose of 2 mg/kg.  

 

Available on backorder

SKU: 25026 - 25 mg Category:

Description

A triterpenoid saponin with diverse biological activities; reduces expression of TNF-α, IL-6, and IL-1β in LPS-stimulated primary mouse macrophages; increases the survival rate in mice with LPS-induced lethal endotoxemia; reduces weight loss, brain edema, blood-brain barrier disruption, and cortex IL-6 and TNF-α protein levels in the ipsilateral cortex in a rat model of traumatic brain injury at 20 mg/kg; reduces the number of nasal rubs and levels of serum TNF-α in an ovalbumin-sensitized allergic rhinitis mouse model in vivo at 8 mg/kg; reduces duration and frequency of epileptiform discharges in rat hippocampal CA1 neurons in a 4-AP seizure model; decreases viability in six HCC, H358 lung and MCF-7 breast cancer, as well as Jurkat and K582 leukemia cell lines at 20 µM; prolongs tumor growth inhibition in LoVo and SW480 HCC mouse xenograft models in vivo at 2 mg/kg


Formal name: (3β,4α,16β)-13,28-epoxy-16,23-dihydroxyolean-11-en-3-yl 6-deoxy-3-O-β-D-glucopyranosyl-β-D-galactopyranoside

Synonyms: 

Molecular weight: 781

CAS: 20736-09-8

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Natural Products|Saponins||Product Type|Biochemicals|Natural Products|Terpenes||Research Area|Cancer|Cell Death||Research Area|Immunology & Inflammation|Allergy||Research Area|Immunology & Inflammation|Innate Immunity|Pattern Recognition||Research Area|Immunology & Inflammation|Innate Immunity|Sepsis/Shock||Research Area|Infectious Disease|Viral Diseases||Research Area|Neuroscience|Seizure Disorders